The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells

Laura Conti, Stefania Lanzardo, Maddalena Arigoni, Roberta Antonazzo, Enrico Radaelli, Daniela Cantarella, Raffaele A. Calogero, Federica Cavallo

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Cancer stem cells (CSCs) are responsible for tumor progression, metastases, resistance to therapy, and tumor recurrence. Therefore, the identification of molecules involved in CSC self-renewal is a necessary step toward more effective therapies. To this aim, through the transcription profiling of the murine ErbB2 tumor cell line TUBO vs. derived CSC-enriched mammospheres, Toll-like receptor 2 (TLR2) was identified as 2-fold overexpressed in CSCs, as confirmed by qPCR and cytofluorimetric analysis. TLR2 signaling inhibition impaired in vitro mammosphere generation in murine TUBO (60%) and 4T1 (30%) and human MDA-MB-231 (50%), HCC1806 (60%), and MCF7 (50%) cells. In CSC, TLR2 was activated by endogenous high-mobility-group box 1 (HMGB1), inducing IB phosphorylation, IL-6 and TGF secretion, and, consequently, STAT3 and Smad3 activation. In vivo TLR2 inhibition blocked TUBO tumor takes in 9/14 mice and induced a 2-fold reduction in lung metastases development by decreasing cell proliferation and vascularization and increasing apoptosis. Collectively, these results demonstrate that murine and human mammary CSCs express TLR2 and its ligand HMGB1; this autocrine loop plays a pivotal role in CSC self-renewal, tumorigenesis, and metastatic ability. These findings, while providing evidence against the controversial use of TLR2 agonists in antitumor therapy, lay out new paths toward the design of anticancer treatments.-Conti, L., Lanzardo, S., Arigoni, M., Antonazzo, R., Radaelli, E., Cantarella, D., Calogero, R. A., Cavallo, F. The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells.

Original languageEnglish
Pages (from-to)4731-4744
Number of pages14
JournalFASEB Journal
Volume27
Issue number12
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Toll-Like Receptor 2
Neoplastic Stem Cells
Stem cells
Breast Neoplasms
Tumors
Neoplasm Metastasis
Neoplasms
Phosphorylation
MCF-7 Cells
Cell proliferation
Transcription
Tumor Cell Line
Interleukin-6
Carcinogenesis
Therapeutics
Chemical activation
Cells
Cell Proliferation
Apoptosis
Ligands

Keywords

  • BOXA
  • Breast carcinoma
  • Endogenous TLR2 ligands
  • MyD88
  • NFB
  • Transcriptome

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology

Cite this

The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells. / Conti, Laura; Lanzardo, Stefania; Arigoni, Maddalena; Antonazzo, Roberta; Radaelli, Enrico; Cantarella, Daniela; Calogero, Raffaele A.; Cavallo, Federica.

In: FASEB Journal, Vol. 27, No. 12, 12.2013, p. 4731-4744.

Research output: Contribution to journalArticle

Conti, L, Lanzardo, S, Arigoni, M, Antonazzo, R, Radaelli, E, Cantarella, D, Calogero, RA & Cavallo, F 2013, 'The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells', FASEB Journal, vol. 27, no. 12, pp. 4731-4744. https://doi.org/10.1096/fj.13-230201
Conti, Laura ; Lanzardo, Stefania ; Arigoni, Maddalena ; Antonazzo, Roberta ; Radaelli, Enrico ; Cantarella, Daniela ; Calogero, Raffaele A. ; Cavallo, Federica. / The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells. In: FASEB Journal. 2013 ; Vol. 27, No. 12. pp. 4731-4744.
@article{ca8d8dde15bb497eb3c79f8b0ebdba4f,
title = "The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells",
abstract = "Cancer stem cells (CSCs) are responsible for tumor progression, metastases, resistance to therapy, and tumor recurrence. Therefore, the identification of molecules involved in CSC self-renewal is a necessary step toward more effective therapies. To this aim, through the transcription profiling of the murine ErbB2 tumor cell line TUBO vs. derived CSC-enriched mammospheres, Toll-like receptor 2 (TLR2) was identified as 2-fold overexpressed in CSCs, as confirmed by qPCR and cytofluorimetric analysis. TLR2 signaling inhibition impaired in vitro mammosphere generation in murine TUBO (60{\%}) and 4T1 (30{\%}) and human MDA-MB-231 (50{\%}), HCC1806 (60{\%}), and MCF7 (50{\%}) cells. In CSC, TLR2 was activated by endogenous high-mobility-group box 1 (HMGB1), inducing IB phosphorylation, IL-6 and TGF secretion, and, consequently, STAT3 and Smad3 activation. In vivo TLR2 inhibition blocked TUBO tumor takes in 9/14 mice and induced a 2-fold reduction in lung metastases development by decreasing cell proliferation and vascularization and increasing apoptosis. Collectively, these results demonstrate that murine and human mammary CSCs express TLR2 and its ligand HMGB1; this autocrine loop plays a pivotal role in CSC self-renewal, tumorigenesis, and metastatic ability. These findings, while providing evidence against the controversial use of TLR2 agonists in antitumor therapy, lay out new paths toward the design of anticancer treatments.-Conti, L., Lanzardo, S., Arigoni, M., Antonazzo, R., Radaelli, E., Cantarella, D., Calogero, R. A., Cavallo, F. The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells.",
keywords = "BOXA, Breast carcinoma, Endogenous TLR2 ligands, MyD88, NFB, Transcriptome",
author = "Laura Conti and Stefania Lanzardo and Maddalena Arigoni and Roberta Antonazzo and Enrico Radaelli and Daniela Cantarella and Calogero, {Raffaele A.} and Federica Cavallo",
year = "2013",
month = "12",
doi = "10.1096/fj.13-230201",
language = "English",
volume = "27",
pages = "4731--4744",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "12",

}

TY - JOUR

T1 - The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells

AU - Conti, Laura

AU - Lanzardo, Stefania

AU - Arigoni, Maddalena

AU - Antonazzo, Roberta

AU - Radaelli, Enrico

AU - Cantarella, Daniela

AU - Calogero, Raffaele A.

AU - Cavallo, Federica

PY - 2013/12

Y1 - 2013/12

N2 - Cancer stem cells (CSCs) are responsible for tumor progression, metastases, resistance to therapy, and tumor recurrence. Therefore, the identification of molecules involved in CSC self-renewal is a necessary step toward more effective therapies. To this aim, through the transcription profiling of the murine ErbB2 tumor cell line TUBO vs. derived CSC-enriched mammospheres, Toll-like receptor 2 (TLR2) was identified as 2-fold overexpressed in CSCs, as confirmed by qPCR and cytofluorimetric analysis. TLR2 signaling inhibition impaired in vitro mammosphere generation in murine TUBO (60%) and 4T1 (30%) and human MDA-MB-231 (50%), HCC1806 (60%), and MCF7 (50%) cells. In CSC, TLR2 was activated by endogenous high-mobility-group box 1 (HMGB1), inducing IB phosphorylation, IL-6 and TGF secretion, and, consequently, STAT3 and Smad3 activation. In vivo TLR2 inhibition blocked TUBO tumor takes in 9/14 mice and induced a 2-fold reduction in lung metastases development by decreasing cell proliferation and vascularization and increasing apoptosis. Collectively, these results demonstrate that murine and human mammary CSCs express TLR2 and its ligand HMGB1; this autocrine loop plays a pivotal role in CSC self-renewal, tumorigenesis, and metastatic ability. These findings, while providing evidence against the controversial use of TLR2 agonists in antitumor therapy, lay out new paths toward the design of anticancer treatments.-Conti, L., Lanzardo, S., Arigoni, M., Antonazzo, R., Radaelli, E., Cantarella, D., Calogero, R. A., Cavallo, F. The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells.

AB - Cancer stem cells (CSCs) are responsible for tumor progression, metastases, resistance to therapy, and tumor recurrence. Therefore, the identification of molecules involved in CSC self-renewal is a necessary step toward more effective therapies. To this aim, through the transcription profiling of the murine ErbB2 tumor cell line TUBO vs. derived CSC-enriched mammospheres, Toll-like receptor 2 (TLR2) was identified as 2-fold overexpressed in CSCs, as confirmed by qPCR and cytofluorimetric analysis. TLR2 signaling inhibition impaired in vitro mammosphere generation in murine TUBO (60%) and 4T1 (30%) and human MDA-MB-231 (50%), HCC1806 (60%), and MCF7 (50%) cells. In CSC, TLR2 was activated by endogenous high-mobility-group box 1 (HMGB1), inducing IB phosphorylation, IL-6 and TGF secretion, and, consequently, STAT3 and Smad3 activation. In vivo TLR2 inhibition blocked TUBO tumor takes in 9/14 mice and induced a 2-fold reduction in lung metastases development by decreasing cell proliferation and vascularization and increasing apoptosis. Collectively, these results demonstrate that murine and human mammary CSCs express TLR2 and its ligand HMGB1; this autocrine loop plays a pivotal role in CSC self-renewal, tumorigenesis, and metastatic ability. These findings, while providing evidence against the controversial use of TLR2 agonists in antitumor therapy, lay out new paths toward the design of anticancer treatments.-Conti, L., Lanzardo, S., Arigoni, M., Antonazzo, R., Radaelli, E., Cantarella, D., Calogero, R. A., Cavallo, F. The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells.

KW - BOXA

KW - Breast carcinoma

KW - Endogenous TLR2 ligands

KW - MyD88

KW - NFB

KW - Transcriptome

UR - http://www.scopus.com/inward/record.url?scp=84890540571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890540571&partnerID=8YFLogxK

U2 - 10.1096/fj.13-230201

DO - 10.1096/fj.13-230201

M3 - Article

C2 - 23970797

AN - SCOPUS:84890540571

VL - 27

SP - 4731

EP - 4744

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 12

ER -